Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Lung Neoplasms 6Colorectal Neoplasms 6Stomach Neoplasms 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Hematologic Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Rectal Neoplasms 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3COVID-19 3Uterine Cervical Neoplasms 2Smoking 2Sarcoma 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma 2Head and Neck Neoplasms 2Head and Neck Carcinoma 2Glioblastoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Xerostomia 1Urologic Neoplasms 1Urologic Diseases 1

Interventions

Standard of Care 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Tobacco Smoking × Standard of Care × Clear all
NCT04691297 2025-12-19

Digitally Enhanced Smoking Cessation for High Risk Smokers

Dana-Farber Cancer Institute

Phase NA Active not recruiting
153 enrolled

Tobacco Smoking, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡